Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone

MYPI2025002173A0Undetermined Publication Date: 2021-02-27SANTEN PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025002173
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-08-27
Filing Date
2020-08-25
Publication Date
2021-02-27
Patent Text Reader

Abstract

An aqueous ophthalmic composition comprising diquafosol or a salt thereof and polyvinylpyrrolidone. An aqueous ophthalmic composition for prevention or treatment of dry eye, comprising diquafosol sodium at a concentration of 3% (w / v), polyvinylpyrrolidone having a K value of 90, and silver nitrate, wherein the aqueous ophthalmic composition is used so as to be instilled into the eye 2 to 4 times a day in a dose of 1 or 2 drops each time. An aqueous ophthalmic composition for prevention or treatment of dry eye, comprising diquafosol sodium at a concentration of 3% (w / v), polyvinylpyrrolidone, and silver nitrate, the aqueous ophthalmic composition being used so as to be instilled into the eye 2 to 4 times a day in a dose of 1 or 2 drops each time, wherein the aqueous ophthalmic composition has a viscosity at 25C of 3 to 30 mPas.
Need to check novelty before this filing date? Find Prior Art